Skip to content
AnalystLens

IDEXX Laboratories 8-K Report, Executive Changes (Feb 13, 2026)

Reports
Leadership Changes
Filing Date
Filed February 13, 2026
Period End
February 13, 2026
Security
IDXX
In the record · 2016–202610-K1110-Q338-K98

IDXX filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 98 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Nov ’20Nov ’20
  2. Material agreement8-K · Oct ’22Oct ’22
  3. Leadership change8-K · Feb ’25Feb ’25

Summary

Summary of the 8-K filed February 13, 2026. Cited figures are marked; the original filing is the authoritative source.

IDEXX Laboratories, Inc. (IDXX) announced a change in its Board of Directors composition.

Ms. M. Anne Szostak has notified the company of her intention to retire from the Board, effective immediately after the 2026 Annual Meeting of Stockholders on May 12, 2026. Her retirement is not due to any disagreements concerning the company's operations or policies, indicating a smooth transition.

The company expressed gratitude for her significant contributions and leadership since 2012. The Board will reduce the size of the Class III directors upon Ms. Szostak's retirement. This reduction, however, will be offset by the previously announced appointment of Michael G.

Erickson, PhD, as a Class II director, also effective immediately following the 2026 Annual Meeting. Investors should note that these changes are procedural and do not appear to reflect any underlying issues with the company's performance or governance.

Key Highlights

  1. Ms. M. Anne Szostak to retire from the Board of Directors effective May 12, 2026.
  2. Retirement is effective immediately following the 2026 Annual Meeting of Stockholders.
  3. Ms. Szostak's retirement is voluntary and not due to any disagreements with the Company or Board.
  4. The Board will reduce the size of the Class III directors upon Ms. Szostak's retirement.
  5. The overall size of the Board will not decrease due to the concurrent appointment of Michael G. Erickson, PhD.
  6. Michael G. Erickson, PhD, will join the Board as a Class II director following the 2026 Annual Meeting.
  7. The company expresses gratitude for Ms. Szostak's service since 2012.

Frequently Asked Questions

  1. Who is leaving the IDEXX Board of Directors?

    Ms. M. Anne Szostak has announced her intention to retire from the Board of Directors of IDEXX Laboratories, Inc.

  2. When will Ms. Szostak's retirement be effective?

    Her retirement will be effective immediately following the Company's 2026 Annual Meeting of Stockholders, which is scheduled for May 12, 2026.

  3. Is Ms. Szostak's retirement due to any negative issues at IDEXX?

    No, the filing explicitly states that Ms. Szostak's decision to retire does not arise from any disagreement with the Company or the Board on any matter relating to the Company's operations, policies, practices, or otherwise.

  4. Will the size of the Board of Directors decrease?

    The size of the Class III directors will be reduced upon Ms. Szostak's retirement. However, the overall size of the Board will not decrease because of the previously announced appointment of Michael G. Erickson, PhD, as a Class II director, which also becomes effective immediately following the 2026 Annual Meeting.